Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
INSIGHT PROVIDER
Top 5%
Sumeet Singh
Head of Research, IPOs & Placements
•
Aequitas Research
Message
Follow
Location:
Singapore
Joined:
04 November 2014
2.8k
Insights
1.7m
Views
1.4k
Followers
Equities
•
Equity Capital Markets
Message
Follow
Regions
More Filters
Refresh
Top Picks Only
Recent
bearish
•
Victory Giant Technology (HuiZhou)
•
14 Oct 2026 13:30
Aequitas: Victory Giant IPO Lockup - Nearly US$800m Cornerstone Release
Victory Giant Technology (2476 HK) (VG) raised around US$2.9bn in its upsized H-share listing in April 2026. The lockup on its cornerstone...
Sumeet Singh
65 Views
Share
bullish
•
Suzhou Dongshan Precision A
•
13 Oct 2026 09:48
Aequitas: Suzhou Dongshan Precision A/H Listing - PHIP Updates and Thoughts on A/H Premium
Suzhou Dongshan Precision (002384 CH), a global PCB and other component provider, aims to raise up to US$3bn in its H-share listing. In this note,...
Sumeet Singh
63 Views
Share
bullish
•
Suzhou Dongshan Precision A
•
12 Oct 2026 11:58
Aequitas: Suzhou Dongshan Precision Manuf A/H IPO - Stock Running on AI, Despite Lacklustre Past
Suzhou Dongshan Precision A (002384 CH, SDPM), a global PCB and other component provider, is now said to be looking to raise up to US$3bn. We will...
Sumeet Singh
424 Views
Share
bullish
•
Biren Technology
•
12 Oct 2026 08:08
Aequitas ECM Weekly (12 October 2026)-Wuxi Bio, CIG, CKD, Infroneer, JIO, ESWIN, Tinci, Transsion
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
Sumeet Singh
100 Views
Share
bearish
•
Fujian Haixi Pharmaceuticals
•
08 Oct 2026 09:50
Aequitas: Fujian Haixi Pharma IPO Lockup - Half of the Company’s Shares Worth US$800m to Be Released
Fujian Haixi Pharmaceuticals (2637 HK) was listed in Oct 2025, when it raised around US$126m in its HK IPO. The lockup on its pre-IPO investors is...
Sumeet Singh
90 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x